Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, By Application, By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
Artificial Intelligence in Drug Discovery Market is estimated to be valued at USD 1,699.0 Mn in 2025 and is expected to reach USD 4,744.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 15.8% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 1,699.0 Mn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
15.80%
2032 Value Projection:
USD 4,744.1 Mn
The Artificial intelligence (AI) is the science and engineering of making intelligent machines, especially intelligent computer programs. The AI techniques are also applicable to drug discovery, drug development, drug repurposing, drug metabolism prediction, drug toxicity analysis, improving pharmaceutical productivity, clinical trials and almost all aspects of pharmaceutical sciences. All these techniques are collectively considered under AIDD (Artificial Intelligence in Drug Discovery).
Market Dynamics:
Increasing technological advancements, product launches by market players, collaborations, research and development agreements and other inorganic growth strategies by market players are major factors expected to augment growth of the global artificial intelligence in drug discovery market over the forecast period.
For instance, on May 16 2023, Google Cloud, in Bio-IT World Conference announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. The Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments.
Key features of the study:
This report provides in-depth analysis of the global artificial intelligence in drug discovery market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial intelligence in drug discovery market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include IBM Corporation (Ibm Watson Health), Exscientia, GNS Healthcare, Alphabet, Inc. (DEEPMIND), Benevolent AI, Biosymetrics, Euretos, Berg LLC., Atomwise, Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial intelligence in drug discovery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial intelligence in drug discovery market.
Detailed Segmentation:
Global Artificial Intelligence in Drug Discovery Market, By Therapeutic Space:
Oncology
Neurodegenerative Diseases
Cardiovascular Diseases
Metabolic Diseases
Infectious Diseases
Other
Global Artificial Intelligence in Drug Discovery Market, By Application:
Drug Optimization & Repurposing
Preclinical Testing
Others
Global Artificial Intelligence in Drug Discovery Market, By Geography:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
Company Profiles:
IBM Corporation (Ibm Watson Health)
Exscientia
GNS Healthcare
Alphabet, Inc. (DEEPMIND)
Benevolent AI
Biosymetrics
Euretos
Berg LLC.
Atomwise, Inc.
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Therapeutic Space
Market Snapshot, By Application
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rising need to curb drug development and discovery costs
Rising prevalence of chronic diseases supporting development of personalized drugs
Big data and information explosion in healthcare and drug discovery
Growing applications of AI in various healthcare areas
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
4. Artificial Intelligence in Drug Discovery Market - Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Artificial Intelligence in Drug Discovery Market, By Therapeutic Space, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurodegenerative Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Metabolic Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
6. Artificial Intelligence in Drug Discovery Market, By Application, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Drug Optimization & Repurposing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Preclinical Testing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
7. Artificial Intelligence in Drug Discovery Market, By Geography, 2020-2032, (US$ Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Space, 2020-2032,(US$ Mn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)